According to the 2013-2014 NHANES survey, about 70% of adults in the United States are overweight or obese. Obesity and overweight substantially increase the risk of morbidity from hypertension; dyslipidemia; type 2 diabetes; coronary heart disease; stroke; gallbladder disease; osteoarthritis; sleep apnea and respiratory problems; and endometrial, breast, prostate, and colon cancers. Higher body weights are also associated with increases in all-cause mortality. The aim of this guideline is to provide useful advice on how to achieve weight reduction and maintenance of a lower body weight. It is also important to note that prevention of further weight gain can be a goal for some patients. Obesity is a chronic disease, and both the patient and the practitioner need to understand that successful treatment requires a life-long effort.
The International Classification of Underweight, Overweight and Obesity according to BMI Risk of developing diabetes and cardiovascular disease occurs at a lower BMI in Asian populations, though the cutoff BMI for increased risk varies from 22-25 kg/m 2 in different Asian populations, and for high risk it varies from 26-31 kg/m 2 . Nevertheless, the WHO recommends that the current classification be retained as the official international classification while encouraging all countries to report data using the additional cut-off BMI ranges to facilitate international comparions 3 .Pregnant women who, on the basis of their pre-pregnant weight, would be classified as obese may encounter certain obstetrical risks. However, the inappropriateness of weight reduction during pregnancy is well recognized (Thomas, 1995) . Hence, this guideline specifically excludes pregnant women.
The table, below, defines relative risk categories according to BMI and waist circumference. It is important to note that these categories denote relative risk, not absolute risk. They relate to the need to institute weight loss therapy, and do not directly define the required intensity of risk factor modification. The latter is determined by estimation of absolute risk based on the presence of associated disease or risk factors. + Increased waist circumference can also be a marker for increased risk even in persons of normal weight.
Classification of Overweight and

Identification of Patients at Very High Absolute Risk
The following disease conditions or target organ damage in hypertensive patients denotes the presence of very high absolute risk that triggers the need for intense risk factor modification as well as disease management. For example, the presence of very high absolute risk indicates the need for aggressive cholesterol-lowering therapy. a. Established coronary heart disease (CHD) 
Identification of Cardiovascular Risk Factors That Impart a High Absolute Risk
Patients can be classified as being at high absolute risk for obesity-related disorders if they have three or more of the multiple risk factors listed below. The presence of high absolute risk increases the intensity of cholesterol lowering therapy and blood pressure management.
• Cigarette smoking
• If not already done, a fasting glucose level and fasting lipid profile should be measured.
Other Risk Factors
Physical inactivity A lack of physical activity imparts an increased risk for both CVD and type 2 diabetes. Physical inactivity enhances the severity of other risk factors, but it also has been shown to be an "independent" risk factor for all-cause mortality or CVD mortality
High triglycerides
In obese patients, elevated serum triglycerides are a marker for increased cardiovascular risk.
Category Serum Triglyceride Levels
Normal triglycerides
Less than 200 mg/dL Borderline-high triglycerides 200 to 400 mg/dL High triglycerides 400 to 1,000 mg/dL Very high triglycerides Greater than 1,000 mg/dL Patients with very high triglycerides are at increased risk for acute pancreatitis and must undergo immediate triglyceride lowering therapy.
Assessment of Patient Motivation
Practitioners need to assess the patient's motivation to enter weight loss therapy, assess the readiness of the patient to implement the plan, and then take appropriate steps to motivate the patient for treatment.
Goals of Weight Loss and Management
The general goals of weight loss and management are: 1. To reduce body weight. 2. To maintain a lower body weight over the long term. 3. To prevent further weight gain. 
Initial
• Target Levels for Weight Loss
The initial target goal of weight loss therapy for overweight patients is to decrease body weight by about 10 percent. If this target can be achieved, consideration can be given to the next step of further weight loss. It is important for patients to realize that even modest weight loss of 3-5%, if sustained, can result in clinically meaningful reduction in risk of diabetes as well as control of existing diabetes and hypertriglyceridemia.
• Rate of Weight Loss A reasonable time line for weight loss is to achieve a 10 percent reduction in body weight over 6 months of therapy. For overweight patients with BMIs in the typical range of 27 to 35, a decrease of 300 to 500 kcal/day will result in weight losses of about 1/2 to 1 lb/week and a 10 percent weight loss in 6 months. For more severely obese patients with BMIs 35, deficits of up to 500 to 1,000 kcal/day will lead to weight losses of about 1 to 2 lb/week and a 10 percent weight loss in 6 months. After 6 months, the rate of weight loss usually declines and weight plateaus because of less energy expenditure at the lower weight. At this point, efforts to maintain weight loss should be put in place. If more weight loss is needed, another attempt at weight reduction can be made. This will require further adjustment of the diet and physical activity prescriptions.
• Prevention of Further Weight Gain
Some patients may not be able to achieve significant weight reduction. In such patients, an important goal is to prevent further weight gain that would exacerbate disease risk. Thus, prevention of further weight gain may justify entering a patient into weight loss therapy. Prevention of further weight gain can be considered a partial therapeutic success for many patients. Moreover, if further weight gain can be prevented, this achievement may be an important first step toward beginning the weight loss process. Primary care practitioners ought to recognize the importance of this goal for those patients who are not able to immediately lose weight. The need to prevent weight gain may warrant maintaining patients in a weight management program for an extended period.
Strategies for Weight Loss and Weight Maintenance 1. Dietary Therapy
Maintaining a caloric deficit of about 500 kcal/day results in weight loss of about one pound per week. Many patients find a calorie prescription (1200-1500 kcal per day for women or 1500-1800 kcal per day for men) to be helpful. There are multiple diet options (low fat diets, low carbohydrate diets, high protein diets, meal-replacement diets, the Mediterranean diet and others) which have been shown to result in comparable weight loss. The diet which the patient finds palatable, affordable and sustainable is the one to which the patient will adhere and the one which should be encouraged/prescribed by the clinician.
Physical Activity
An increase in physical activity is an important component of weight loss therapy since it leads to increased expenditure of energy. Increased physical activity may also inhibit food intake in overweight patients. Physical activity is primarily helpful in maintaining a desirable weight once weight loss has been achieved. In addition, sustained physical activity has the benefit of reducing overall CHD risk beyond that produced by weight reduction alone.
Strategies to Increase Physical Activity
Extremely obese persons may need to start with simple exercises that can gradually be intensified. The practitioner must decide whether exercise testing for cardiopulmonary disease is needed before embarking on a new physical activity regimen. This decision should be based on a patient's age, symptoms, and concomitant risk factors.
• Initial activities may be walking or swimming at a slow pace.
• With time, depending on progress, the amount of weight lost, and functional capacity, the patient may engage in more strenuous activities. Some of these include fitness walking, cycling, rowing, cross-country skiing, aerobic dancing, and rope jumping. • Jogging provides a high-intensity aerobic exercise, but can lead to orthopedic injury. If jogging is desired, the patient's ability to do this must first be assessed. The availability of a safe environment for the jogger is also a necessity.
• Competitive sports, such as tennis and volleyball, can provide an enjoyable form of physical activity for many, but again, care must be taken to avoid injury, especially in older people.
Behavior Therapy
The goal of behavior therapy is to alter the eating and activity habits of an obese patient. Behavioral strategies to reinforce changes in diet and physical activity can produce a weight loss in obese adults in the range of 10 percent of baseline weight over 4 months to 1 year. Multi-component behavioral intervention programs with at least 12 sessions have been shown to be more effective than programs with fewer sessions or lower treatment intensity. Unless a patient acquires a new set of eating and physical activity habits, long-term weight reduction is unlikely to succeed. The acquisition of new habits is particularly important for long-term weight maintenance at a lower weight. Most patients return to baseline weights in the absence of continued intervention.
• Self-monitoring of both eating habits and physical activity-Objectifying one's own behavior through observation and recording is a key step in behavior therapy. Patients should be taught to record the amount and types of food they eat, the caloric values, and nutrient composition. Keeping a record of the frequency, intensity, and type of physical activity likewise will add insight to personal behavior • Stress management-Stress can trigger dysfunctional eating patterns, and stress management can defuse situations leading to overeating. Coping strategies, meditation, and relaxation techniques all have been successfully employed to reduce stress. In addition, inadequate sleep has been associated with risk of obesity though causality has not been proven.
• Stimulus control-Identifying stimuli that may encourage incidental eating enables individuals to limit their exposure to high-risk situations. Examples of stimulus control strategies include learning to shop carefully for healthy foods, keeping high-calorie foods out of the house, limiting the times and places of eating, and consciously avoiding situations in which overeating occurs.
• Problem solving-Self-corrections of problem areas related to eating and physical activity.
Approaches to problem solving include identifying weight-related problems, generating or brainstorming possible solutions and choosing one, planning and implementing the healthier alternative, and evaluating the outcome of possible changes in behavior.
• Contingency management-Behavior can be changed by use of rewards for specific actions, such as increasing time spent walking or reducing consumption of specific foods Rewards can come from either the professional team or from the patients themselves. For example, selfrewards can be monetary or social and should be encouraged.
• Cognitive restructuring-Unrealistic goals and inaccurate beliefs about weight loss and body image need to be modified to help change self-defeating thoughts and feelings that undermine weight loss efforts. Rational responses designed to replace negative thoughts are encouraged.
• Social support-A strong system of social support can facilitate weight reduction. Family members, friends, or colleagues can assist an individual in maintaining motivation and providing positive reinforcement.
Treatment of Obese Individuals with Binge Eating Disorder
If a patient suffers from binge eating disorder (BED), consideration can be given to referring the patient to a health professional who specializes in BED treatment. Behavioral approaches to BED associated with obesity have been derived from cognitive behavior therapy (CBT) used to treat bulimia nervosa. Pharmacotherapy with SSRI's is also efficacious but less so than cognitive behavioral therapy in treating BED.
Combined Therapy
To achieve the greatest likelihood of success from weight loss therapy, the combination of dietary therapy with an LCD, increased physical activity, and behavior therapy will be required. therapy and increased physical activity in a weight loss regimen will provide the best opportunity for weight loss, and hopefully for long-term weight control. In order to achieve weight loss, such a regimen should be maintained for at least 6 months before considering pharmacotherapy.
Pharmacotherapy
It is important to remember that the major role of medications should be to help patients stay on a diet and physical activity plan while losing weight. Medication cannot be expected to continue to be effective in weight loss or weight maintenance once it has been stopped.
Therefore, an initial trial period of several weeks with a given drug or combination of drugs may help determine their efficacy in a given patient. If a patient does not respond to a drug with reasonable weight loss, the physician should reassess the patient to determine adherence to the medication regimen and adjunctive therapies, or consider the need for dosage adjustment. If the patient continues to be unresponsive to the medication, or serious adverse effects occur, the physician should consider its discontinuation. Medications are to be used in conjunction with lifestyle modification (i.e. dietary interventions, behavioral therapy, and increased physical activity).
Pharmacotherapy is recommended for individuals with a BMI >30 kg/m2 or a waist circumference >35 inches (women) or 40 inches (men) and for patients with a BMI >27 kg/m2 with the presence of an additional comorbid condition or more than one risk factor for 'weight-related' disease such as hypercholesterolemia, diabetes, hypertension.
Many herbal preparations have been used for weight loss; however, the NIH states that herbal preparations are not recommended as part of weight loss program. Only caffeine and ephedra (no longer available) have well performed studies, but this is only the short term. Overall the risks outweigh the benefits. 
Medication
Surgery for Weight Loss
Surgery is one option for weight reduction for some patients with severe and resistant obesity. The aim of surgery is to modify the gastrointestinal tract to reduce net food intake. Bariatric surgery should be considered in patients with BMI ≥ 40 or in those with BMI ≥ 35 with obesity-related comorbid conditions who have not responded to diet, exercise and/or pharmacologic attempts to lose weight. Post bariatric
